Post-discovery priorities: Streamlining your molecule’s route to IND

Article

Time to market is paramount for many companies starting to consider post-discovery development and strategic plans for bringing a molecule into clinical trials and beyond. Strategies and tactics for shortening timelines often involve trade-offs related to risk and future needs, making early-phase decision-making a balancing act for even the most promising molecules. Read what our experts how to say about the critical considerations that impact timing and commercialization.

Download article

Ready to discuss your project?

Connect with us